adminMicroVi

We are honored to see that among the most Highly Cited Researchers internationally, there are several scientist from our region Asturias (North of Spain), including two of the members of our company. Abelardo Margolles co-founder [...]

Just before the end of the year @Microviable received approval  of competitive funding as a collaborator on a project to develop Next Generation Probiotics for sports performance.

We want to thank our clientes and stakeholders the trust they have placed on us in this 2021. We are thrilled to be present in new countries and more to come. It has been a [...]

Microviable Therapeutics SL, December 22nd, 2021, a preclinical stage biotechnology company developing microbiota-based products today announced that it has completed preclinical analyses on safety and colonization capability of their unique Human Purified Microbiota (HPMTM) product. [...]

Recognizing the true pioneers in their fields over the last decade, demonstrated by the production of multiple highly-cited papers that rank in the top 1% by citations for field and year in the #WebOfScience™. Of the [...]

Microviable Therapeutics welcomes Ignacio Montero, PhD on board. With a PhD in microbiology, extensive experience in R&D and a MS in Bioinformatics, Ignacio joins the team to work on the bioinformatic and genomics platform. Noteworthy, [...]

We are excited to announce the appointment of Rosa del Campo, PhD, MD to our Scientific Advisory Board. As part of our strategic vision and further expansion, we are glad to work closely with clinicians [...]

Microviable Therapeutics welcomes Lara Dos Santos Rodríguez on board. Lara will performed her internships with us as part of her training to obtain the BS Biology at the University of Oviedo.